Nick Devoogdt Selected Research

Nick Devoogdt Research Topics

Disease

54	Neoplasms (Cancer) 01/2022 - 05/2003
17	Breast Neoplasms (Breast Cancer) 12/2021 - 07/2011
10	Inflammation (Inflammations) 03/2021 - 12/2012
5	Carcinoma (Carcinomatosis) 11/2019 - 07/2010
4	Multiple Myeloma 01/2022 - 12/2014
4	Neoplasm Metastasis (Metastasis) 04/2020 - 05/2003
4	Atherosclerosis 12/2019 - 01/2018
4	Atherosclerotic Plaque (Atheroma) 01/2018 - 10/2014
3	Melanoma (Melanoma, Malignant) 01/2022 - 06/2019
3	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 03/2009
3	Amyloidosis 01/2017 - 12/2016
3	Hepatitis 01/2017 - 02/2015
2	Residual Neoplasm 01/2021 - 03/2012
2	Neuroblastoma 01/2020 - 11/2017
2	Brain Neoplasms (Brain Tumor) 08/2019 - 12/2017
2	Experimental Arthritis 10/2016 - 05/2013
2	Rheumatoid Arthritis 05/2014 - 05/2013
1	COVID-19 11/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Calcinosis 10/2019
1	Triple Negative Breast Neoplasms 07/2019
1	Hemorrhage 01/2018
1	Lymphoma (Lymphomas) 12/2017
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2017
1	Alcoholic Fatty Liver 01/2017
1	Choline Deficiency 01/2017

Drug/Important Bio-Agent (IBA)

41	Single-Domain AntibodiesIBA 01/2022 - 05/2010
14	Radioisotopes (Radionuclides)IBA 01/2022 - 03/2012
9	Biomarkers (Surrogate Marker)IBA 12/2021 - 05/2003
8	Mannose ReceptorIBA 01/2021 - 08/2012
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2010
6	AntibodiesIBA 11/2021 - 01/2013
6	N-succinimidyl 4-guanidinomethyl-3-iodobenzoateIBA 04/2020 - 04/2014
6	AntigensIBA 11/2019 - 05/2010
6	Pharmaceutical PreparationsIBA 10/2019 - 05/2014
5	Monoclonal AntibodiesIBA 01/2022 - 06/2019
5	human ERBB2 proteinIBA 01/2021 - 07/2011
5	Trastuzumab (Herceptin)FDA Link 04/2020 - 01/2013
5	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 12/2019 - 09/2016
4	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 09/2021 - 05/2013
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 10/2011
4	Secretory Leukocyte Peptidase InhibitorIBA 03/2009 - 05/2003
3	Immune Checkpoint InhibitorsIBA 11/2021 - 01/2019
3	LigandsIBA 06/2021 - 01/2017
3	oxidized low density lipoproteinIBA 10/2019 - 10/2014
3	GelsolinIBA 01/2017 - 12/2016
2	Chelating AgentsIBA 04/2020 - 03/2012
2	LectinsIBA 10/2019 - 10/2014
2	Fluorine-18IBA 10/2019 - 01/2019
2	Biological ProductsIBA 08/2019 - 01/2017
2	Amyloid (Amyloid Fibrils)IBA 01/2017 - 01/2017
2	GoldIBA 01/2017 - 06/2011
2	Concanavalin AIBA 01/2017 - 02/2015
2	Peptide Hydrolases (Proteases)FDA Link 03/2009 - 05/2003
2	Protease Inhibitors (Protease Inhibitor)IBA 03/2009 - 05/2003
1	ParaproteinsIBA 01/2022
1	OvalbuminIBA 01/2022
1	Lutetium-177IBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	CalreticulinIBA 01/2022
1	RadiopharmaceuticalsIBA 12/2021
1	Broadly Neutralizing AntibodiesIBA 11/2021
1	avelumabIBA 09/2021
1	ConnexinsIBA 03/2021
1	Actinium-225IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Pentetic Acid (DTPA)FDA LinkGeneric 04/2020
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 04/2020
1	AcidsIBA 01/2020
1	B7-H1 AntigenIBA 01/2020
1	N-chlorosuccinimideIBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2019
1	Surface Antigens (Surface Antigen)IBA 11/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2019
1	Gallium-68IBA 10/2019
1	FluoridesIBA 10/2019
1	VaccinesIBA 08/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 06/2019
1	AlbuminsIBA 10/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Rituximab (Mabthera)FDA Link 12/2017
1	EpitopesIBA 12/2017
1	pertuzumabIBA 12/2017
1	Insulin (Novolin)FDA Link 11/2017
1	Epidermal Growth Factor (EGF)IBA 01/2017
1	CholesterolIBA 01/2017
1	LDL CholesterolIBA 01/2017
1	C-Type Lectins (C-Type Lectin)IBA 01/2017

Therapy/Procedure

30	Therapeutics 01/2022 - 10/2011
8	Precision Medicine 01/2022 - 12/2014
3	Radioimmunotherapy 11/2019 - 03/2012
3	Intravenous Injections 06/2019 - 07/2011
1	Computer-Assisted Surgery (Image Guided Surgery) 01/2022
1	Radiotherapy 01/2020
1	Microbubbles 12/2019
1	Immunotherapy 01/2019
1	Combination Drug Therapy (Combination Chemotherapy) 01/2018
1	Intravenous Administration 12/2017